Chiral resolution of rac-4-cyano-1-aminoindane, a key intermediate of ozanimod, was successfully achieved through a combination of crystallization and enantioselective dissolution up to 96%ee. The disastereomeric salt with di-p-toluoyl-L-tartaric acid was...
We have successfully performed chiral resolution of a key synthetic intermediate of ozanimod, rac-4-cyano-1-aminoindane, by combining crystallization and enantioselective dissolution. 4-Cyano-1-aminoindane forms a diastereomeric salt with di-p-toluoyl-L-tartaric acid, however the single crystallization gave moderate enantiomeric excess, which indicated the formation of solid solution. The formation of solid solution is typical trouble in chiral resolution, and the limitation of enrichment by the crystallization was indicated by the construction of binary and ternary phase diagrams. Thorough phase diagram study revealed the solid-state landscape of the diastereomeric salt and determined the condition for chiral resolution. Additionally, further enrichment was achieved by following enantioselective dissolution using the difference in dissolution rates of the diastereomeric pairs. This combination of crystallization and dissolution demonstrated chiral resolution of 4-cyano-1-aminoindane up to 96%, and proposed a new solution to the solid solution formation which is typical trouble of chiral resolution for the first time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.